Calcium antagonists: still appropriate as first line antihypertensive agents.
Epstein
M
M
Department of Veterans Affairs Medical Center, University of Miami School of Medicine, Florida 33125, USA.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D003327:Coronary Disease / Q000188:drug therapy; D003692:Delayed-Action Preparations; D018450:Disease Progression; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology; D014665:Vasodilator Agents / Q000494:pharmacology
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D014665:Vasodilator Agents